Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Radiology
•
Inflammatory arthritis
•
Nuclear Medicine
When would you consider utilizing bone scintigraphy in the assessment of inflammatory arthritis?
Answer from: at Community Practice
When it's a case of negative RA disease or when considering a neoplastic, gammopathy with myeloma...
Sign In
or
Register
to read more
Answer from: at Community Practice
I would also consider using triple phase bone scan to assess the blood pool phase which may help determine sites of active inflammation. This may also help guide sites for intervention/injection.
Sign In
or
Register
to read more
14606
22338
Related Questions
When screening for malignancy, do you order CT with contrast (or) both with and without contrast?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
In what clinical situations do you consider azathioprine for treatment of inflammatory arthritis?
What are some situations where a non-prednisone steroid would be more appropriate than prednisone?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
What additional workup would you perform to evaluate a new onset of spontaneous hemarthrosis?